Clinical Research:

MCAP has been involved in clinical research programs for over 30 years. We offer a diverse range of research opportunities to address critical issues related to living with HIV.

Our research opportunities include treatment studies, social and behavioral studies, and long-term studies looking at the health and development of babies exposed to HIV treatments in the womb.

Click Below to go to any of these sections:

RESEARCH OPPORTUNITIES FOR ALL COMMUNITY MEMBERS

COMMUNITY ADVISORY BOARD (CAB)

Our Community Advisory Board (CAB) is a committee formed of community members, clients, and members of the MCAP team. The CAB is dedicated to advising MCAP on the needs of the community. The goal of this partnership is to ensure that stakeholders have an opportunity to voice their opinions about the programs at MCAP, hear the results of our research, and take an active role in shaping the future of the program. Our research would not be possible without the guidance and dedication of the CAB members.

The CAB meets quarterly, and is open to all participants and clients at MCAP and members of the community at large.

RESEARCH OPPORTUNITIES FOR YOUNG ADULTS

AMP UP:

Adolescent Master Protocol

A study looking at the long-term health and wellness effects of being exposed to HIV treatment in the womb and growing up living with HIV.

For participants 18 years of age and older who have been living with HIV since birth, or who are not living with HIV but were born to a mother with HIV.

https://clinicaltrials.ucsd.edu/trial/NCT02119702

RESEARCH OPPORTUNITIES FOR PREGNANT PEOPLE

SMARTT:

Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-infected Women

A study for pregnant people and their babies that is looking at the long-term effects of being exposed to HIV and antiretroviral medications during pregnancy. Participants enroll during their pregnancy, and the study will follow their babies from birth until age 18.

For participants who are at least 13 weeks pregnant and who are taking antiretroviral medications.

https://clinicaltrials.ucsd.edu/trial/NCT01310023

IMPAACT 2026:

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

A study for pregnant people and their babies that is looking at how well antiretroviral and tuberculosis medications are working during pregnancy, and how much of the medications are in the baby’s system after delivery. This study is also looking at parents who choose to breastfeed to see how much antiretroviral medication gets passed to the baby in breastmilk.

For pregnant people living with HIV who are taking certain antiretroviral medications or who are considering breastfeeding their babies after delivery. Please contact the study team to see if your medication regimen may qualify you for this protocol.

https://clinicaltrials.gov/study/NCT04518228